297a-coc-redacted
Dieses Dokument ist Teil der Anfrage „Briefverkehr mit BioNtech“
BioNTech Manufacturing GmbH SIONTZCTHA Manufacturing An der Goldgrube 12 55131 Mainz, Germany phone: +49-6131-9084-0 fax: +49-6131-9084-390 Certificate of Compliance (No.: ) Product: COMIRNATYTM Lot/Batch No.: Date of Manufacture 03 Dec 2021 \ | Batch size: j | Packaging: GC-Vial 2 mL (10 vials/pack) | Strength/Potency: 30 ug BNT162b2 per dose (0.3 mL) Volume per vial: 2.25 mL Dosage Form: Dispersion for i.m. injection — Retest date/Expiry date: 31 May 2022 - | Destination: All EU Member States, Norway, Iceland and Liechtenstein Authorization No.: EU/1/20/1528/002 Name and Address of Manufacturer (OP release): Manufacturing authorization number /GMP-Certificate: Pa Remarks: N/A Certification Statement: I hereby certify that allthe manufacturing stages of this batch of finished product have been carried out in full compliance with the GMP requirements ofthe EU and with the requirements ofthe EU Marketing Authorisation. 2 1 JAN 2022 Date, Signature ofthe Qualified Person